IFNA1 and chronic myelogenous leukemia, BCR-ABL1 positive: We have tested the ability of IFN to slow the leukocyte doubling time (Ldt) and to prolong remissions induced by busulphan in 14 patients with chronic granulocytic leukaemia (CGL).